Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Synthon Chiragenics (Fine Chemicals business)

M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of carbohydrates-based chiral technologies. The company's chiral technology portfolio is developed through a series of in-house and licensing developments that include catalytic asymmetric transfer hydrogenation and catalytic asymmetric cyanohydrin synthesis.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • 7 Deer Park Drive
  • Monmouth Junction, NJ 08852
  • United States

Synthon Chiragenics (Fine Chemicals business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Synthon Chiragenics (Fine Chemicals business)‘s full profile, request access.

Request full access to PitchBook

Synthon Chiragenics (Fine Chemicals business) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Synthon Chiragenics (Fine Chemicals business)‘s full profile, request access.

Request full access to PitchBook